跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,212 条关于
“Santen S.A.”
全部
2,212
临床试验
1,036
药物
356
机构
606
资讯
214
2个月前
FDA to Convene Advisory Committee to Review Sydnexis's SYD-101 for Pediatric Progressive Myopia
去年
Oncodesign Precision Medicine Presents Positive Phase 1 Data for RIPK2 Inhibitor OPM-101 in Healthy Volunteers
去年
RemeGen and Santen Strike $1.3 Billion Licensing Deal for Dual-Target Ophthalmic Drug RC28-E
9个月前
Santen and Singapore Eye Research Institute Launch $21 Million Collaboration to Develop Disease-Modifying Eye Therapies
3个月前
Harrow Re-Launches VERKAZIA, First FDA-Approved Steroid-Sparing Therapy for Vernal Keratoconjunctivitis
23天前
FDA Grants Type B Pre-IND Meeting for RTX-NP (MabionCD20) in Immune Thrombocytopenia
4年前
EDAP Announces Positive Pre-clinical Results for HIFU Ablation in Pancreatic Cancer Treatment
去年
Urteste Expands Cancer Diagnostic Pipeline with Focus on Early Detection
去年
PharmaMar Expands Global Reach of Zepzelca with Argentina Approval and Merck Partnership for Japan
3个月前
Cosmos Health Subsidiary Acquires International Nanotechnology Patent, Expands GMP Manufacturing Platform
第 1 页,共 22 页
上一页
下一页